Adam M Veness

SVP, General Counsel and Sec., Dianthus Therapeutics, Inc. /DE/

Bought, 12 months

$0.0M

Sold, 12 months

$4.6M

Companies

Latest trade

Aug 10, 2026

Companies

Dianthus Therapeutics, Inc. /DE/SVP, General Counsel and Sec. −$4.6M

Trades

DNTH Sold 16,167 shares at $110.38 · planned $1.8M Aug 10

DNTH Sold 3,833 shares at $110.70 · planned $0.4M Aug 7

DNTH Sold 30,000 shares at $80.80 · planned $2.4M Jun 17

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.